GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology - Wikidata - awgldk - TriplyDB

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

http://www.wikidata.org/entity/Q31060385

about

Gonadotrophin-releasing hormone antagonists for assisted reproductive technology A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression.A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis Reassessing the feasibility of the zygote score for predicting embryo viability in IVF/ICSI using the GnRH antagonist protocol compared to the long protocol A new ovarian response prediction index (ORPI): implications for individualised controlled ovarian stimulation Cessation of gonadotropin-releasing hormone antagonist on triggering day in flexible multiple-dose protocol: A randomized controlled study.Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles.Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols.Increased Uterine NK cell numbers and perforin expression during the implantation phase in IVF Cycles with GnRH Antagonist Protocol.Dysmorphic patterns are associated with cytoskeletal alterations in human oocytes.Impact of oocytes with CLCG on ICSI outcomes and their potential relation to pesticide exposure.Effect of oocyte dysmorphisms on intracytoplasmic sperm injection cycle outcomes in normal ovarian responders.The association of follicular fluid volume with human oolemma stretchability during intracytoplasmic sperm injection.GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type.Association of follicular fluid volume with membrane stretchability of human metaphase II oocytes following the gonadotropin-releasing hormone agonist protocol during intracytoplasmic sperm injection

P2860

Q24185849-47003C5D-E5D2-44A2-9C90-AC4AF1D6A835 Q34339901-220012A9-F1D2-4ADA-B41A-8069D01D39BE Q34394666-F9A3C788-4172-49E8-A16C-C1DAF08197AA Q36267719-7446B195-658E-4083-B33C-2506A49AA730 Q36594368-D63D9374-233C-44BF-97F8-FB3F287D85FE Q37022407-1E8098DD-2DBF-42D9-A4BD-2D0BC265B23D Q37138027-1E9C82B3-D7B7-4FD7-AB75-E0BD854F15EA Q37370067-29386274-B08C-48EA-9601-3FB9059E0C94 Q37550317-96E8D316-DA90-4C14-B1D4-AA683614FB2F Q38883816-FE1B4E85-4710-44A1-A080-B81427930872 Q40978269-0690E20A-8084-4CFD-A0AA-FBBCF4D7043E Q41288990-A2E5741E-3260-49A1-B065-E3FAAFC76EB3 Q42261641-7332EA0D-847F-496C-A885-60524CBEFAF2 Q47990608-E60F4BC6-CC0C-468F-A3D9-388270DDDCE6 Q56550339-2F58584A-C62E-4B2D-8AF7-8E358E4C0AD8

P2860

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

http://www.wikidata.org/entity/Q31060385

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

@ast

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

@en

type

label

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

@ast

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

@en

prefLabel

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

@ast

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

@en

P1433

Q31060385-50BD87A3-178E-4B69-A895-A7E67DFFEF02

P1476

Q31060385-9F395F21-07D6-48EF-BB6B-C3C9D25DF263

P2093

Q31060385-4546F0A8-422D-40FB-93E5-8C1196E0951D

Q31060385-4FD5ED89-CA13-48A8-988A-EB0D3701DF3B

Q31060385-6E23E588-A38C-465A-9224-B131EC3C16FF

Q31060385-97C7FEC8-AC86-48B8-9753-B719A44DDFA7

Q31060385-B6B6D925-CC95-4E02-AC53-8B23B6E19AC9

Q31060385-B7971F84-AF23-41DA-BA38-7C6FEE733AB7

Q31060385-BC76A86E-592E-451F-A652-70448842CAA8

Q31060385-E6863B83-E9A9-4387-9358-0DE13209F372

Q31060385-E8C2D05B-8369-4B3C-B3AF-24798BD202C0

Q31060385-F7354859-A5FE-463E-B1E8-5A435CDB1E73

P2860

Q31060385-02212454-AB35-4F2A-92DB-C2EB376BD5A2

Q31060385-05BE50B3-25F1-4F79-8ACD-85B58A42DB4D

Q31060385-073AEA92-EE79-40A0-AC2A-0F6F2F9E66D3

Q31060385-0997DC51-6737-427A-B951-86341137B82A

Q31060385-099C0904-F90F-4A67-B11D-EEFAAC24EF1F

Q31060385-0BF093A7-FD4D-4150-9F36-BD5B80F689D4

Q31060385-108EFB58-4370-45E2-8C0D-4D9ED4BF1955

Q31060385-1A7DD659-AF36-4419-8BDD-11CEAB0B0DE6

Q31060385-1B76B740-09A5-4C7A-9CAF-62C2E778073D

Q31060385-2007600F-4B71-4B87-88C6-5D96E55AA62C

P2888

Q31060385-2FF5AE67-7FC9-40B2-AB7A-DB01B7EE4B40

P304

Q31060385-9F05E179-DDC2-40DE-B95F-AEE0A6DD97CE

P31

Q31060385-EAF77A76-F64F-4072-89AE-79B906A954F4

P356

Q31060385-B0EC4E74-F01C-4DE1-B4AF-F35E42F71F3A

P478

Q31060385-427F8591-53FF-47CF-BF83-8F53FD92BD80

P577

Q31060385-6A0789E2-E441-429D-8E23-A2621AFA5B3F

P5875

Q31060385-038D4C28-5BE8-464C-A515-BCC7DCDBF088

P6179

Q31060385-F845B477-DB72-41BB-B9FD-9BDCE6A3FE02

P698

Q31060385-1DCF7914-B754-471F-8523-D11C015F892A

P932

Q31060385-F4CA7271-4BFD-4F80-ADDE-2ED072512EFB

P356

1477-7827-10-33

P1433

Reproductive Biology and Endocrinology

P1476

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

@en

P2093

Ana L Mauri

http://www.w3.org/2001/XMLSchema#string

Ana Marcia M Cota

http://www.w3.org/2001/XMLSchema#string

Andreia Nicoletti

http://www.w3.org/2001/XMLSchema#string

Claudia G Petersen

http://www.w3.org/2001/XMLSchema#string

Fabiana C Massaro

http://www.w3.org/2001/XMLSchema#string

Joao Batista A Oliveira

http://www.w3.org/2001/XMLSchema#string

José G Franco

http://www.w3.org/2001/XMLSchema#string

Liliane F I Silva

http://www.w3.org/2001/XMLSchema#string

Mario Cavagna

http://www.w3.org/2001/XMLSchema#string

Ricardo L R Baruffi

http://www.w3.org/2001/XMLSchema#string

P2860

Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction

GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry.

Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists.

Relationship between oocyte abnormal morphology and intracytoplasmic sperm injection outcomes: a meta-analysis.

Predictive value of oocyte morphology in human IVF: a systematic review of the literature.

Significance of metaphase II human oocyte morphology on ICSI outcome.

Gonadotropin-releasing hormone antagonists for assisted reproductive techniques: are there clinical differences between agents?

An oocyte score for use in assisted reproduction.

Lipofuscin bodies in human oocytes as an indicator of oocyte quality.

Coarse granulation in the perivitelline space and IVF-ICSI outcome.

P2888

1477-7827-10-33

P304

33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7827-10-33

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224864852

http://www.w3.org/2001/XMLSchema#string

P6179

1027738818

http://www.w3.org/2001/XMLSchema#string

P698

22540993

http://www.w3.org/2001/XMLSchema#string

P932

3464873

http://www.w3.org/2001/XMLSchema#string